Literature DB >> 18193118

Differences in taste between two polyethylene glycol preparations.

Maria M Szojda1, Chris J J Mulder, Richelle J F Felt-Bersma.   

Abstract

BACKGROUND AND AIMS: Polyethylene glycol preparations (PEG) are increasingly used for chronic constipation in both adults and children. There are some suggestions that PEG 4000 with orange flavour (Forlax) tastes better than PEG 3350 which contains salt (Movicolon). Poor taste is an important factor for non-compliance and is one of the leading causes of therapy failure. The aim of the study was to compare the taste of two commonly used PEG preparations, PEG 4000 and PEG 3350.
METHODS: A double-blind, cross over randomised trial. A hundred people were recruited by advertisement. All tasted both preparations without swallowing and after tasting each of the preparations, they rinsed their mouths. Then a score, on a 5-point scale, was given for both preparations.
RESULTS: 100 volunteers were included (27 males and 73 females, mean age 36). The taste score for PEG 4000 (mean 3.9, SD 0.7) was significantly better than for PEG 3350 (mean 2.7, SD 0.7) (p<0.0001, Wilcoxon matched pairs test). No difference in gender or age was observed. The volunteers which tasted PEG 3350 liked it more, when they tasted it first rather than when they tasted it after PEG 4000 (p<0.0001). The order in which volunteers tested PEG 4000 had no influence on the taste results.
CONCLUSION: PEG 4000 tastes better than PEG 3350. This may have implications for patient compliance and effectiveness of treatment in patients with chronic constipation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18193118

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  14 in total

1.  Prospective evaluation of small bowel preparation with bisacodyl and sodium phosphate for capsule endoscopy.

Authors:  Andreas Franke; Frank Hummel; Phillip Knebel; Christoph Antoni; Ulrich Bocker; Manfred V Singer; Matthias Lohr
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

Review 2.  American Gastroenterological Association technical review on constipation.

Authors:  Adil E Bharucha; John H Pemberton; G Richard Locke
Journal:  Gastroenterology       Date:  2013-01       Impact factor: 22.682

3.  Paediatric oncology patient preference for oral nutritional supplements in a clinical setting.

Authors:  Jennifer Cohen; Kate Rosen; Ken K Russell; Claire E Wakefield; Belinda Goodenough
Journal:  Support Care Cancer       Date:  2010-07-10       Impact factor: 3.603

Review 4.  Chronic Constipation.

Authors:  Adil E Bharucha; Arnold Wald
Journal:  Mayo Clin Proc       Date:  2019-05-01       Impact factor: 7.616

5.  [Pharmacological treatment of constipation].

Authors:  S Müller-Lissner
Journal:  Internist (Berl)       Date:  2013-04       Impact factor: 0.743

6.  Constipation in adults: diagnosis and management.

Authors:  Vanessa C Costilla; Amy E Foxx-Orenstein
Journal:  Curr Treat Options Gastroenterol       Date:  2014-09

7.  Comparison of polyethylene glycol with and without electrolytes in the treatment of constipation in elderly institutionalized patients: a randomized, double-blind, parallel-group study.

Authors:  Lauri Seinelä; Ulla Sairanen; Tarmo Laine; Sangita Kurl; Tiina Pettersson; Pertti Happonen
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 8.  Agents that act luminally to treat diarrhoea and constipation.

Authors:  Stacy Menees; Richard Saad; William D Chey
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-09-04       Impact factor: 46.802

Review 9.  Mechanisms, Evaluation, and Management of Chronic Constipation.

Authors:  Adil E Bharucha; Brian E Lacy
Journal:  Gastroenterology       Date:  2020-01-13       Impact factor: 22.682

10.  Efficacy and tolerability of peg-only laxative on faecal impaction and chronic constipation in children. A controlled double blind randomized study vs a standard peg-electrolyte laxative.

Authors:  Francesco Savino; Serena Viola; Maiullari Erasmo; Giovanni Di Nardo; Salvatore Oliva; Salvatore Cucchiara
Journal:  BMC Pediatr       Date:  2012-11-15       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.